SCHEDULE 13G: Disciplined Growth Investors Discloses 5.1% Stake in Myriad Genetics
Beneficial Ownership Disclosure
Disciplined Growth Investors, Inc. has filed a Schedule 13G, revealing a 5.1% beneficial ownership stake in Myriad Genetics Inc. as of March 31, 2025.
Summary
- Disciplined Growth Investors, Inc. reported beneficial ownership of 4,292,976 shares of Myriad Genetics Inc. Common Stock.
- This ownership represents 5.1% of the total class of securities.
- The filing was made under Rule 13d-1(b), indicating that Disciplined Growth Investors, Inc. is an institutional investor, specifically an Investment Adviser.
- The shares are stated to be acquired and held in the ordinary course of business, not for the purpose of changing or influencing the control of Myriad Genetics Inc.
Sentiment
Score: 5
Explanation: The document is a factual, routine regulatory filing disclosing an ownership stake. It contains no positive or negative operational or financial news about the company itself, thus maintaining a neutral sentiment.
Positives
- An institutional investor, Disciplined Growth Investors, Inc., holds a significant 5.1% stake in Myriad Genetics Inc., which can be interpreted as a vote of confidence in the company's prospects.
Negatives
- The Schedule 13G filing itself does not contain any negative information regarding Myriad Genetics Inc.
Risks
- The Schedule 13G filing does not contain information about specific risks related to Myriad Genetics Inc.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of an institutional investor's passive ownership stake in a publicly traded company within the biotechnology/genetics industry. It does not provide specific insights into broader industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling confidence from a large investor.
- Investment Professionals: Offers data points on institutional holdings for portfolio analysis and tracking.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement |
| 05/15/2025 | Date of filing of this statement |
Keywords
Myriad Genetics Inc., Disciplined Growth Investors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Equity Stake, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.